Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 4
Submit an article Journal homepage
395
Views
36
CrossRef citations to date
0
Altmetric
Drug Evaluation

Prospect of rindopepimut in the treatment of glioblastoma

Aladine A. ElsamadicyDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USAView further author information
,
Pakawat ChongsathidkietDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA;Department of Pathology, Duke University Medical Center, Durham, NC, USAView further author information
,
Rupen DesaiDepartment of Neurosurgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USAView further author information
,
Karolina WoronieckaDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA;Department of Pathology, Duke University Medical Center, Durham, NC, USAView further author information
,
S. Harrison FarberDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USAView further author information
,
Peter E. FecciDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA;Department of Pathology, Duke University Medical Center, Durham, NC, USAView further author information
&
John H. SampsonDuke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA;Department of Pathology, Duke University Medical Center, Durham, NC, USACorrespondence[email protected]
View further author information
 show all
Pages 507-513 | Received 17 Nov 2016, Accepted 22 Feb 2017, Published online: 05 Mar 2017

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now
Vaishali Y. Londhe & Varada Date. (2020) Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Review of Vaccines 19:5, pages 407-417.
Read now
David B. Altshuler, Padma Kadiyala, Felipe J. Nuñez, Fernando M. Nuñez, Stephen Carney, Mahmoud S. Alghamri, Maria B. Garcia-Fabiani, Antonela S. Asad, Alejandro J. Nicola Candia, Marianela Candolfi, Joerg Lahann, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein & Maria G. Castro. (2020) Prospects of biological and synthetic pharmacotherapies for glioblastoma. Expert Opinion on Biological Therapy 20:3, pages 305-317.
Read now
Linda Ye, Shaokang Ma, Bruce W. Robinson & Jenette Creaney. (2019) Immunotherapy strategies for mesothelioma – the role of tumor specific neoantigens in a new era of precision medicine. Expert Review of Respiratory Medicine 13:2, pages 181-192.
Read now
Ziren Kong, Yu Wang & Wenbin Ma. (2018) Vaccination in the immunotherapy of glioblastoma. Human Vaccines & Immunotherapeutics 14:2, pages 255-268.
Read now

Articles from other publishers (31)

Nisha V. Kalayil, Pallavi P. Paul, Showkhiya Y. Khan & Shona S. D'Souza. (2023) Advancing Glioblastoma Therapy: Promising Research in Precision Medicine. Drug Delivery Letters 13:4, pages 264-282.
Crossref
Masoumeh Eliyasi Dashtaki, Zahra Moradi, Yousef Moradi, Elham Asadi Farsani & Sorayya Ghasemi. (2023) Estimating the Survival Rate in Glioblastoma Multiforme Patients who Received a Peptide Vaccine: A Systematic Review and Meta-analysis. Current Drug Targets 24:12, pages 998-1007.
Crossref
Alessio Ardizzone, Rossella Basilotta, Alessia Filippone, Lelio Crupi, Marika Lanza, Sofia Paola Lombardo, Cristina Colarossi, Dorotea Sciacca, Salvatore Cuzzocrea, Emanuela Esposito & Michela Campolo. (2023) Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. Cells 12:6, pages 841.
Crossref
Shenglan Li, Can Wang, Jinyi Chen, Yanjie Lan, Weichunbai Zhang, Zhuang Kang, Yi Zheng, Rong Zhang, Jianyu Yu & Wenbin Li. (2023) Signaling pathways in brain tumors and therapeutic interventions. Signal Transduction and Targeted Therapy 8:1.
Crossref
Daniel Kreatsoulas, Chelsea Bolyard, Bill X. Wu, Hakan Cam, Pierre Giglio & Zihai Li. (2022) Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence. Journal of Hematology & Oncology 15:1.
Crossref
Efosa Amadasu, Eric Panther & Brandon Lucke-Wold. (2022) Characterization and Treatment of Spinal Tumors. Intensive Care Research 2:3-4, pages 76-95.
Crossref
Amir Barzegar Behrooz, Zahra Talaie & Amir Syahir. (2022) Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable. Pharmaceutics 14:8, pages 1697.
Crossref
Fatima A. Hamid, Cheryl L. Marker, Michael D. Raleigh, Aaron Khaimraj, Scott Winston, Paul R. Pentel & Marco Pravetoni. (2022) Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine 40:23, pages 3244-3252.
Crossref
Li Li, Jianhong Chen, Yue Ming, Bin Li, Ruoqiu Fu, Dongyu Duan, Ziwei Li, Rui Ni, Xianfeng Wang, Yueling Zhou & Lin Zhang. (2022) The Application of Peptides in Glioma: A Novel Tool for Therapy. Current Pharmaceutical Biotechnology 23:5, pages 620-633.
Crossref
Igor Bryukhovetskiy. (2022) Cell‑based immunotherapy of glioblastoma multiforme (Review). Oncology Letters 23:4.
Crossref
Aline de Cristo Soares Alves, Vladimir Lavayen, Amanda de Fraga Dias, Franciele Aline Bruinsmann, Juliete Nathali Scholl, Rodrigo Cé, Fernanda Visioli, Ana Maria Oliveira Battastini, Silvia Stanisçuaski Guterres, Fabrício Figueiró & Adriana Raffin Pohlmann. (2021) EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma. Nanomedicine 16:20, pages 1775-1790.
Crossref
Sanjeev Chawla, Vanessa Shehu, Pradeep K. Gupta, Kavindra Nath & Harish Poptani. (2021) Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas. International Journal of Molecular Sciences 22:8, pages 3867.
Crossref
Alice Giotta Lucifero & Sabino Luzzi. (2021) Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I). Brain Sciences 11:3, pages 386.
Crossref
Shalini Sundramurthi Chelliah, Ervin Ashley Lourdes Paul, Muhamad Noor Alfarizal Kamarudin & Ishwar Parhar. (2021) Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 26:4, pages 1169.
Crossref
Manali Tilak, Jennifer Holborn, Laura A. New, Jasmin Lalonde & Nina Jones. (2021) Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme. International Journal of Molecular Sciences 22:4, pages 1831.
Crossref
Luiza Steffens, Mabilly Cox Holanda de Barros Dias, Pablo Ricardo Arantes, Jeferson Gustavo Henn, Michael Nugent & Dinara Jaqueline Moura. 2021. Advances and Challenges in Pharmaceutical Technology. Advances and Challenges in Pharmaceutical Technology 355 394 .
Elmira Mohtashami, Negar Shafaei-Bajestani, Hamid Mollazadeh, Seyed Hadi Mousavi, Mohammad Jalili-Nik, Amirhossein Sahebkar & Amir R. Afshari. (2020) The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review. Current Drug Metabolism 21:8, pages 564-578.
Crossref
Xianhui Kang, Yiyang Zheng, Wandong Hong, Xixi Chen, Huiting Li, Baojun Huang, Zhenyang Huang, Hongli Tang & Wujun Geng. (2020) Recent Advances in Immune Cell Therapy for Glioblastoma. Frontiers in Immunology 11.
Crossref
Charles P. Couturier, Shamini Ayyadhury, Phuong U. Le, Javad Nadaf, Jean Monlong, Gabriele Riva, Redouane Allache, Salma Baig, Xiaohua Yan, Mathieu Bourgey, Changseok Lee, Yu Chang David Wang, V. Wee Yong, Marie-Christine Guiot, Hamed Najafabadi, Bratislav Misic, Jack Antel, Guillaume Bourque, Jiannis Ragoussis & Kevin Petrecca. (2020) Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Nature Communications 11:1.
Crossref
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2019) Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy. Cancers 11:9, pages 1314.
Crossref
Oleksandr Glavatskyi, Irina Vasileva, Olena Galanta, Hennadii Khmelnytskyi, Irina Shuba, Konstantin Kardash & Oksana Zemskova. (2019) DETERMINATION OF MOLECULAR GENETIC MARKERS IN PROGNOSIS OF THE EFFECTIVENESS OF TREATMENT OF MALIGNANT INTRACEREBRAL BRAIN TUMORS. EUREKA: Health Sciences 4, pages 25-34.
Crossref
Boqi Dong, Liying Wang, Shu Nie, Xin Li, Yue Xiao, Lei Yang, Xiuping Meng, Peiyan Zhao, Cuiyun Cui, Liqun Tu, Wenting Lu, Wei Sun & Yongli Yu. (2018) Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice. Vaccine 36:52, pages 8148-8157.
Crossref
Alberto Grandi, Laura Fantappiè, Carmela Irene, Silvia Valensin, Michele Tomasi, Simone Stupia, Riccardo Corbellari, Elena Caproni, Ilaria Zanella, Samine J. Isaac, Luisa Ganfini, Luca Frattini, Enrico König, Assunta Gagliardi, Simona Tavarini, Chiara Sammicheli, Matteo Parri & Guido Grandi. (2018) Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models. Frontiers in Oncology 8.
Crossref
Jessica Silva, Ana Miranda, João Sousa, Alberto Pais & Carla Vitorino. 2018. Biopharmaceuticals. Biopharmaceuticals.
A. Zygogianni, M. Protopapa, A. Kougioumtzopoulou, F. Simopoulou, S. Nikoloudi & V. Kouloulias. (2018) From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence. Clinical and Translational Oncology 20:8, pages 989-1003.
Crossref
Hamed Akbari, Spyridon Bakas, Jared M Pisapia, MacLean P Nasrallah, Martin Rozycki, Maria Martinez-Lage, Jennifer J D Morrissette, Nadia Dahmane, Donald M O’Rourke & Christos Davatzikos. (2018) In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature . Neuro-Oncology 20:8, pages 1068-1079.
Crossref
Toshimitsu Yamaoka, Motoi Ohba & Tohru Ohmori. (2017) Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms. International Journal of Molecular Sciences 18:11, pages 2420.
Crossref
Alberto Grandi, Michele Tomasi, Ilaria Zanella, Luisa Ganfini, Elena Caproni, Laura Fantappiè, Carmela Irene, Luca Frattini, Samine J. Isaac, Enrico König, Francesca Zerbini, Simona Tavarini, Chiara Sammicheli, Fabiola Giusti, Ilaria Ferlenghi, Matteo Parri & Guido Grandi. (2017) Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles. Frontiers in Oncology 7.
Crossref
Ju Yang, Jing Yan & Baorui Liu. (2017) Targeting EGFRvIII for glioblastoma multiforme. Cancer Letters 403, pages 224-230.
Crossref
Vikram C. Prabhu, Kevin P. Barton, Susan Walsh, Ewa Borys & Edward Melian. (2017) Recurrent Malignant Gliomas: Treatment Options and Their Effect on Patient's Quality of Life. World Neurosurgery 103, pages 906-910.
Crossref
Frank Lieberman. (2017) Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Research 6, pages 1892.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.